Su Y - Search Results

1

Network-based Pharmacology and In vitro Validation Reveal that Galangin Induces Apoptosis in Bladder Cancer Cells by Promoting the P53 Signaling Pathway.

Long X, Chen L, Yang J, Dong T, Cheng Q, Wang W, Zou Y, Su Y, Dai W, Chen B, Zhou X. Long X, et al. Among authors: su y. Anticancer Agents Med Chem. 2023;23(7):847-857. doi: 10.2174/1871520623666221026121600. Anticancer Agents Med Chem. 2023. PMID: 36305128

2

Apatinib Inhibits Bladder Cancer through Suppression of the VEGFR2- PI3K-AKT Signaling Pathway as Revealed by Network Pharmacology and in vitro Experimental Verification.

Wang W, Chen L, Yang J, Hu D, Yang Y, Dong T, Long X, Zou Y, Li J, Ma X, Dai W, Zhou X, Chen B, Su Y. Wang W, et al. Among authors: su y. Comb Chem High Throughput Screen. 2023;26(13):2380-2392. doi: 10.2174/1386207326666230228101008. Comb Chem High Throughput Screen. 2023. PMID: 36852790

3

Network pharmacology and in vitro experiments reveal that Noscapine induces ROS-mediated apoptosis and cell cycle arrest via PI3K/Akt/FoxO3a signaling pathway in human bladder cancer cells.

Su Y, Chen L, Yang J. Su Y, et al. Curr Cancer Drug Targets. 2023 Jul 6. doi: 10.2174/1568009623666230706153936. Online ahead of print. Curr Cancer Drug Targets. 2023. PMID: 37415366

4

Targeting Thbs1 reduces bladder remodeling caused by partial bladder outlet obstruction via the FGFR3/p-FGFR3 pathway.

Long J, Yang Y, Yang J, Chen L, Wang S, Zhou X, Su Y, Liu C. Long J, et al. Among authors: su y. Neurourol Urodyn. 2024 Feb;43(2):516-526. doi: 10.1002/nau.25366. Epub 2023 Dec 18. Neurourol Urodyn. 2024. PMID: 38108523

5

Development and Validation of Anoiki-Related Lncrna Signature Prediction Model for KIRC Prognosis.

Su Y, Yang J. Su Y, et al. Comb Chem High Throughput Screen. 2024 Jan 4. doi: 10.2174/0113862073271880231114100544. Online ahead of print. Comb Chem High Throughput Screen. 2024. PMID: 38305400

6

Network pharmacology and in vitro experiments reveal sophoridine-induced apoptosis and G₁ phase arrest via ROS-dependent PI3K/Akt/FoxO3a pathway activation in human bladder cancer cells.

Su Y, Chen L, Yang J. Su Y, et al. Chem Biol Drug Des. 2024 Feb;103(2):e14476. doi: 10.1111/cbdd.14476. Chem Biol Drug Des. 2024. PMID: 38346772

7

Hesperetin Inhibits Bladder Cancer Cell Proliferation and Promotes Apoptosis and Cycle Arrest by PI3K/AKT/FoxO3a and ER Stress-mitochondria Pathways.

Su Y, Chen L, Yang J. Su Y, et al. Curr Med Chem. 2024 Feb 13. doi: 10.2174/0109298673283888231217174702. Online ahead of print. Curr Med Chem. 2024. PMID: 38357946

8

MicroRNA-145 suppresses epithelial to mesenchymal transition in pancreatic cancer cells by inhibiting TGF-β signaling pathway.

Chen S, Xu J, Su Y, Hua L, Feng C, Lin Z, Huang H, Li Y. Chen S, et al. Among authors: su y. J Cancer. 2020 Feb 19;11(9):2716-2723. doi: 10.7150/jca.34902. eCollection 2020. J Cancer. 2020. PMID: 32201542 Free PMC article.

9

Identification and functional analyses of differentially expressed metabolites in early stage endometrial carcinoma.

Shi K, Wang Q, Su Y, Xuan X, Liu Y, Chen W, Qian Y, Lash GE. Shi K, et al. Among authors: su y. Cancer Sci. 2018 Apr;109(4):1032-1043. doi: 10.1111/cas.13532. Epub 2018 Mar 25. Cancer Sci. 2018. PMID: 29436067 Free PMC article.

10

Solamargine inhibits gastric cancer progression via inactivation of STAT3/PD‑L1 signaling.

Liu X, Song L, Liu W, Liu B, Liu L, Su Y. Liu X, et al. Among authors: su y. Mol Med Rep. 2025 Feb;31(2):35. doi: 10.3892/mmr.2024.13400. Epub 2024 Nov 22. Mol Med Rep. 2025. PMID: 39575463 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18,947 results

Search Page

Filters